|
1
|
Shan J, Shen J, Liu L, Xia F, Xu C, Duan
G, Xu Y, Ma Q, Yang Z, Zhang Q, et al: Nanog regulates self-renewal
of cancer stem cells through the insulin-like growth factor pathway
in human hepatocellular carcinoma. Hepatology. 56:1004–1014. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sun C, Sun L, Jiang K, Gao DM, Kang XN,
Wang C, Zhang S, Huang S, Qin X, Li Y, et al: NANOG promotes liver
cancer cell invasion by inducing epithelial-mesenchymal transition
through NODAL/SMAD3 signaling pathway. Int J Biochem Cell Biol.
45:1099–1108. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hashimoto N, Tsunedomi R, Yoshimura K,
Watanabe Y, Hazama S and Oka M: Cancer stem-like sphere cells
induced from de-differentiated hepatocellular carcinoma-derived
cell lines possess the resistance to anti-cancer drugs. BMC Cancer.
14:7222014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li X, Luo Q and Song G: Novel therapeutic
strategies for treatment of hepatocellular carcinoma: Targeting
intervention on liver cancer stem cells. Sheng Wu Yi Xue Gong Cheng
Xue Za Zhi. 30:894–898. 2013.In Chinese. PubMed/NCBI
|
|
5
|
Wang J, Levasseur DN and Orkin SH:
Requirement of Nanog dimerization for stem cell self-renewal and
pluripotency. Proc Natl Acad Sci USA. 105:6326–6331. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pan G and Thomson JA: Nanog and
transcriptional networks in embryonic stem cell pluripotency. Cell
Res. 17:42–49. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang J, Rao S, Chu J, Shen X, Levasseur
DN, Theunissen TW and Orkin SH: A protein interaction network for
pluripotency of embryonic stem cells. Nature. 444:364–368. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hyslop L, Stojkovic M, Armstrong L, Walter
T, Stojkovic P, Przyborski S, Herbert M, Murdoch A, Strachan T and
Lako M: Downregulation of NANOG induces differentiation of human
embryonic stem cells to extraembryonic lineages. Stem Cells.
23:1035–1043. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mitsui K, Tokuzawa Y, Itoh H, Segawa K,
Murakami M, Takahashi K, Maruyama M, Maeda M and Yamanaka S: The
homeoprotein Nanog is required for maintenance of pluripotency in
mouse epiblast and ES cells. Cell. 113:631–642. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chambers I, Colby D, Robertson M, Nichols
J, Lee S, Tweedie S and Smith A: Functional expression cloning of
Nanog, a pluripotency sustaining factor in embryonic stem cells.
Cell. 113:643–655. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang ML, Chiou SH and Wu CW: Targeting
cancer stem cells: Emerging role of Nanog transcription factor.
Onco Targets Ther. 6:1207–1220. 2013.PubMed/NCBI
|
|
12
|
Iv Santaliz-Ruiz LE, Xie X, Old M, Teknos
TN and Pan Q: Emerging role of nanog in tumorigenesis and cancer
stem cells. Int J Cancer. 135:2741–2748. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang L, Zhang X, Zhang M, Zhang J, Sheng
Y, Sun X, Chen Q and Wang LX: Increased Nanog expression promotes
tumor development and cisplatin resistance in human esophageal
cancer cells. Cell Physiol Biochem. 30:943–952. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu Y, Zhu H, Shan H, Lu J, Chang X, Li X,
Lu J, Fan X, Zhu S, Wang Y, et al: Knockdown of Oct4 and Nanog
expression inhibits the stemness of pancreatic cancer cells. Cancer
Lett. 340:113–123. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang D, Lu P, Zhang H, Luo M, Zhang X, Wei
X, Gao J, Zhao Z and Liu C: Oct-4 and Nanog promote the
epithelial-mesenchymal transition of breast cancer stem cells and
are associated with poor prognosis in breast cancer patients.
Oncotarget. 5:10803–10815. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang CE, Yu CC, Hu FW, Chou MY and Tsai
LL: Enhanced chemosensitivity by targeting Nanog in head and neck
squamous cell carcinomas. Int J Mol Sci. 15:14935–14948. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ding Y, Yu AQ, Li CL, Fang J, Zeng Y and
Li DS: TALEN-mediated Nanog disruption results in less
invasiveness, more chemosensitivity and reversal of EMT in Hela
cells. Oncotarget. 5:8393–8401. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chanrion M, Kuperstein I, Barrière C, El
Marjou F, Cohen D, Vignjevic D, Stimmer L, Paul-Gilloteaux P,
Bièche I, Tavares SR, et al: Concomitant Notch activation and p53
deletion trigger epithelial-to-mesenchymal transition and
metastasis in mouse gut. Nat Commun. 5:50052014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rangel MC, Karasawa H, Castro NP, Nagaoka
T, Salomon DS and Bianco C: Role of Cripto-1 during
epithelial-to-mesenchymal transition in development and cancer. Am
J Pathol. 180:2188–2200. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Katsuyama T, Akmammedov A, Seimiya M, Hess
SC, Sievers C and Paro R: An efficient strategy for TALEN-mediated
genome engineering in Drosophila. Nucleic Acids Res. 41:e1632013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li T, Huang S, Zhao X, Wright DA,
Carpenter S, Spalding MH, Weeks DP and Yang B: Modularly assembled
designer TAL effector nucleases for targeted gene knockout and gene
replacement in eukaryotes. Nucleic Acids Res. 39:6315–6325. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu H, Lau CH, Goh SL, Liang Q, Chen C, Du
S, Phang RZ, Tay FC, Tan WK, Li Z, et al: Baculoviral transduction
facilitates TALEN-mediated targeted transgene integration and
Cre/LoxP cassette exchange in human-induced pluripotent stem cells.
Nucleic Acids Res. 41:e1802013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang D, Zhu W, Wang Y, Sun C, Zhang KQ
and Yang J: Molecular tools for functional genomics in filamentous
fungi: Recent advances and new strategies. Biotechnol Adv.
31:1562–1574. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kucia M, Jankowski K, Reca R, Wysoczynski
M, Bandura L, Allendorf DJ, Zhang J, Ratajczak J and Ratajczak MZ:
CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol
Histol. 35:233–245. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Müller A, Homey B, Soto H, Ge N, Catron D,
Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al:
Involvement of chemokine receptors in breast cancer metastasis.
Nature. 410:50–56. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang XQ, Ng RK, Ming X, Zhang W, Chen L,
Chu AC, Pang R, Lo CM, Tsao SW, Liu X, et al: Epigenetic regulation
of pluripotent genes mediates stem cell features in human
hepatocellular carcinoma and cancer cell lines. PLoS One.
8:e724352013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Han J, Zhang F, Yu M, Zhao P, Ji W, Zhang
H, Wu B, Wang Y and Niu R: RNA interference-mediated silencing of
NANOG reduces cell proliferation and induces G0/G1 cell cycle
arrest in breast cancer cells. Cancer Lett. 321:80–88. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Casas E, Kim J, Bendesky A, Ohno-Machado
L, Wolfe CJ and Yang J: Snail2 is an essential mediator of
Twist1-induced epithelial mesenchymal transition and metastasis.
Cancer Res. 71:245–254. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Acloque H, Adams MS, Fishwick K,
Bronner-Fraser M and Nieto MA: Epithelial-mesenchymal transitions:
The importance of changing cell state in development and disease. J
Clin Invest. 119:1438–1449. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chiou SH, Wang ML, Chou YT, Chen CJ, Hong
CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS, et al:
Coexpression of Oct4 and Nanog enhances malignancy in lung
adenocarcinoma by inducing cancer stem cell-like properties and
epithelial-mesenchymal transdifferentiation. Cancer Res.
70:10433–10444. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Meng HM, Zheng P, Wang XY, Liu C, Sui HM,
Wu SJ, Zhou J, Ding YQ and Li J: Over-expression of Nanog predicts
tumor progression and poor prognosis in colorectal cancer. Cancer
Biol Ther. 9:295–302. 2010. View Article : Google Scholar
|
